Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 597

1.

Maintenance of clinical response and consistent safety profile with up to three years of continuous treatment with guselkumab: results from the VOYAGE 1 and VOYAGE 2 trials.

Reich K, Griffiths CEM, Gordon KB, Papp KA, Song M, Randazzo B, Li S, Shen YK, Han C, Kimball AB, Armstrong AW, Foley P, Blauvelt A.

J Am Acad Dermatol. 2019 Dec 3. pii: S0190-9622(19)33132-9. doi: 10.1016/j.jaad.2019.11.040. [Epub ahead of print]

PMID:
31809827
2.

Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.

Karuppuchamy T, Tyler CJ, Lundborg LR, Pérez-Jeldres T, Kimball AK, Clambey ET, Jedlicka P, Rivera-Nieves J.

Inflamm Bowel Dis. 2019 Dec 6. pii: izz174. doi: 10.1093/ibd/izz174. [Epub ahead of print]

PMID:
31807751
3.

Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice.

Kimball AB, Crowley JJ, Papp K, Calimlim B, Duan Y, Fleischer AB, Sobell J.

J Eur Acad Dermatol Venereol. 2019 Dec 4. doi: 10.1111/jdv.16132. [Epub ahead of print]

PMID:
31800124
4.

The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.

Kimball A, Dichtel LE, Nyer MB, Mischoulon D, Fisher LB, Cusin C, Dording CM, Trinh NH, Yeung A, Haines MS, Sung JC, Pinna G, Rasmusson AM, Carpenter LL, Fava M, Klibanski A, Miller KK.

Psychoneuroendocrinology. 2019 Nov 14:104512. doi: 10.1016/j.psyneuen.2019.104512. [Epub ahead of print]

PMID:
31780185
5.

Update: Interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung Injury - United States, October 2019.

Siegel DA, Jatlaoui TC, Koumans EH, Kiernan EA, Layer M, Cates JE, Kimball A, Weissman DN, Petersen EE, Reagan-Steiner S, Godfred-Cato S, Moulia D, Moritz E, Lehnert JD, Mitchko J, London J, Zaki SR, King BA, Jones CM, Patel A, Meaney Delman D, Koppaka R; Lung Injury Response Clinical Working Group; Lung Injury Response Epidemiology/Surveillance Group.

Am J Transplant. 2019 Dec;19(12):3420-3428. doi: 10.1111/ajt.15690. No abstract available.

PMID:
31778010
6.

Global Health Security: Rethinking Joint External Evaluations to Ensure Readiness?

Asghar RJ, Kimball AM, Khan AS.

Health Secur. 2019 Nov 26. doi: 10.1089/hs.2019.0104. [Epub ahead of print] No abstract available.

PMID:
31770009
7.

In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019.

Klippel Z, Kimball A, Tekle C.

Blood Cancer J. 2019 Nov 19;9(12):89. doi: 10.1038/s41408-019-0250-4. No abstract available.

8.

Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk.

Kleyn CE, Talbot PS, Mehta NN, Sampogna F, Bundy C, Ashcroft DM, Kimball AB, Kerkhof PCM, Griffiths CEM, Valenzuela F, van der Walt JM, Aberra T, Puig L.

Acta Derm Venereol. 2019 Nov 19. doi: 10.2340/00015555-3375. [Epub ahead of print]

9.

Investigating race and gender in age at onset of hidradenitis suppurativa.

Morss PC, Porter ML, Savage KT, Rosales Santillan M, Giannotti N, Kimball AB.

J Eur Acad Dermatol Venereol. 2019 Nov 17. doi: 10.1111/jdv.16095. [Epub ahead of print] No abstract available.

PMID:
31736152
10.

Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injuries - United States, October 2019.

Moritz ED, Zapata LB, Lekiachvili A, Glidden E, Annor FB, Werner AK, Ussery EN, Hughes MM, Kimball A, DeSisto CL, Kenemer B, Shamout M, Garcia MC, Reagan-Steiner S, Petersen EE, Koumans EH, Ritchey MD, King BA, Jones CM, Briss PA, Delaney L, Patel A, Polen KD, Sives K, Meaney-Delman D, Chatham-Stephens K; Lung Injury Response Epidemiology/Surveillance Group; Lung Injury Response Epidemiology/Surveillance Task Force.

MMWR Morb Mortal Wkly Rep. 2019 Nov 1;68(43):985-989. doi: 10.15585/mmwr.mm6843e1.

11.

Sepsis Induces Prolonged Epigenetic Modifications in Bone Marrow and Peripheral Macrophages Impairing Inflammation and Wound Healing.

Davis FM, Schaller MA, Dendekker A, Joshi AD, Kimball AS, Evanoff H, Wilke C, Obi AT, Melvin WJ, Cavassani K, Scola M, Carson B, Moser S, Blanc V, Engoren M, Moore BB, Kunkel SL, Gallagher KA.

Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2353-2366. doi: 10.1161/ATVBAHA.119.312754. Epub 2019 Sep 5.

PMID:
31644352
12.

Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury - United States, October 2019.

Siegel DA, Jatlaoui TC, Koumans EH, Kiernan EA, Layer M, Cates JE, Kimball A, Weissman DN, Petersen EE, Reagan-Steiner S, Godfred-Cato S, Moulia D, Moritz E, Lehnert JD, Mitchko J, London J, Zaki SR, King BA, Jones CM, Patel A, Delman DM, Koppaka R; Lung Injury Response Clinical Working Group; Lung Injury Response Epidemiology/Surveillance Group.

MMWR Morb Mortal Wkly Rep. 2019 Oct 18;68(41):919-927. doi: 10.15585/mmwr.mm6841e3.

13.

E-cigarette Product Use, or Vaping, Among Persons with Associated Lung Injury - Illinois and Wisconsin, April-September 2019.

Ghinai I, Pray IW, Navon L, O'Laughlin K, Saathoff-Huber L, Hoots B, Kimball A, Tenforde MW, Chevinsky JR, Layer M, Ezike N, Meiman J, Layden JE.

MMWR Morb Mortal Wkly Rep. 2019 Oct 4;68(39):865-869. doi: 10.15585/mmwr.mm6839e2.

14.

Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data.

Marvel J, Vlahiotis A, Sainski-Nguyen A, Willson T, Kimball A.

BMJ Open. 2019 Sep 30;9(9):e030579. doi: 10.1136/bmjopen-2019-030579.

15.

Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Preliminary Report.

Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde M, Navon L, Hoots B, Salvatore PP, Elderbrook M, Haupt T, Kanne J, Patel MT, Saathoff-Huber L, King BA, Schier JG, Mikosz CA, Meiman J.

N Engl J Med. 2019 Sep 6. doi: 10.1056/NEJMoa1911614. [Epub ahead of print]

PMID:
31491072
16.

Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies.

Kimball AB, Papp KA, Reich K, Gooderham M, Li Q, Cichanowitz N, La Rosa C, Blauvelt A.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18484. [Epub ahead of print]

PMID:
31487406
17.

Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council.

Strober B, Ryan C, van de Kerkhof P, van der Walt J, Kimball AB, Barker J, Blauvelt A; International Psoriasis Council Board Members and Councilors.

J Am Acad Dermatol. 2019 Aug 16. pii: S0190-9622(19)32573-3. doi: 10.1016/j.jaad.2019.08.026. [Epub ahead of print]

18.

High-Dimensional Characterization of IL-10 Production and IL-10-Dependent Regulation during Primary Gammaherpesvirus Infection.

Kimball AK, Oko LM, Kaspar RE, van Dyk LF, Clambey ET.

Immunohorizons. 2019 Mar 21;3(3):94-109. doi: 10.4049/immunohorizons.1800088.

PMID:
31356152
19.

The Histone Methyltransferase Setdb2 Modulates Macrophage Phenotype and Uric Acid Production in Diabetic Wound Repair.

Kimball AS, Davis FM, denDekker A, Joshi AD, Schaller MA, Bermick J, Xing X, Burant CF, Obi AT, Nysz D, Robinson S, Allen R, Lukacs NW, Henke PK, Gudjonsson JE, Moore BB, Kunkel SL, Gallagher KA.

Immunity. 2019 Aug 20;51(2):258-271.e5. doi: 10.1016/j.immuni.2019.06.015. Epub 2019 Jul 23.

PMID:
31350176
20.

Genetic basis for skin youthfulness.

Flood KS, Houston NA, Savage KT, Kimball AB.

Clin Dermatol. 2019 Jul - Aug;37(4):312-319. doi: 10.1016/j.clindermatol.2019.04.007. Epub 2019 Apr 26.

PMID:
31345318
21.

Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis.

Yosipovitch G, Dong Y, Burge R, Zhu B, Shrom D, Kimball AB.

Acta Derm Venereol. 2019 Oct 1;99(11):1031-1032. doi: 10.2340/00015555-3254. No abstract available.

22.

Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial.

Liebowitz M, Katheria A, Sauberan J, Singh J, Nelson K, Hassinger DC, Aucott SW, Kaempf J, Kimball A, Fernandez E, Carey WA, Perez J, Serize A, Wickremasinghe A, Dong L, Derrick M, Wolf IS, Heuchan AM, Sankar M, Bulbul A, Clyman RI; PDA-TOLERATE (PDA: TOLEave it alone or Respond And Treat Early) Trial Investigators.

J Pediatr. 2019 Oct;213:222-226.e2. doi: 10.1016/j.jpeds.2019.05.049. Epub 2019 Jun 27.

PMID:
31255386
23.

Differences in Trabecular Plate and Rod Structure in Premenopausal Women Across the Weight Spectrum.

Schorr M, Fazeli PK, Bachmann KN, Faje AT, Meenaghan E, Kimball A, Singhal V, Ebrahimi S, Gleysteen S, Mickley D, Eddy KT, Misra M, Klibanski A, Miller KK.

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4501-4510. doi: 10.1210/jc.2019-00843.

PMID:
31219580
24.

A Randomized Placebo-Controlled Trial of Low-Dose Testosterone Therapy in Women With Anorexia Nervosa.

Kimball A, Schorr M, Meenaghan E, Bachmann KN, Eddy KT, Misra M, Lawson EA, Kreiger-Benson E, Herzog DB, Koman S, Keane RJ, Ebrahimi S, Schoenfeld D, Klibanski A, Miller KK.

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4347-4355. doi: 10.1210/jc.2019-00828.

PMID:
31219558
25.

SIRT3 Regulates Macrophage-Mediated Inflammation in Diabetic Wound Repair.

Boniakowski AM, denDekker AD, Davis FM, Joshi A, Kimball AS, Schaller M, Allen R, Bermick J, Nycz D, Skinner ME, Robinson S, Obi AT, Moore BB, Gudjonsson JE, Lombard D, Kunkel SL, Gallagher KA.

J Invest Dermatol. 2019 Dec;139(12):2528-2537.e2. doi: 10.1016/j.jid.2019.05.017. Epub 2019 Jun 15.

PMID:
31207226
26.

TNF-α inhibitors in the treatment of hidradenitis suppurativa.

Savage KT, Flood KS, Porter ML, Kimball AB.

Ther Adv Chronic Dis. 2019 May 27;10:2040622319851640. doi: 10.1177/2040622319851640. eCollection 2019. Review.

27.

Multidimensional analysis of Gammaherpesvirus RNA expression reveals unexpected heterogeneity of gene expression.

Oko LM, Kimball AK, Kaspar RE, Knox AN, Coleman CB, Rochford R, Chang T, Alderete B, van Dyk LF, Clambey ET.

PLoS Pathog. 2019 Jun 5;15(6):e1007849. doi: 10.1371/journal.ppat.1007849. eCollection 2019 Jun.

28.

Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups.

Orlowski RZ, Moreau P, Niesvizky R, Ludwig H, Oriol A, Chng WJ, Goldschmidt H, Yang Z, Kimball AS, Dimopoulos M.

Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):522-530.e1. doi: 10.1016/j.clml.2019.04.018. Epub 2019 May 2.

29.

Biologic Treatment for Hidradenitis Suppurativa.

Flood KS, Porter ML, Kimball AB.

Am J Clin Dermatol. 2019 Oct;20(5):625-638. doi: 10.1007/s40257-019-00439-5. Review.

PMID:
31140067
30.

Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti-PD-1 response in NSCLC.

Bullock BL, Kimball AK, Poczobutt JM, Neuwelt AJ, Li HY, Johnson AM, Kwak JW, Kleczko EK, Kaspar RE, Wagner EK, Hopp K, Schenk EL, Weiser-Evans MC, Clambey ET, Nemenoff RA.

Life Sci Alliance. 2019 May 27;2(3). pii: e201900328. doi: 10.26508/lsa.201900328. Print 2019 Jun.

31.

Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review.

Popatia S, Flood KS, Golbari NM, Patel PV, Olbricht SM, Kimball AB, Porter ML.

J Am Acad Dermatol. 2019 Dec;81(6):1308-1318. doi: 10.1016/j.jaad.2019.05.024. Epub 2019 May 16.

PMID:
31103568
32.

Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study.

Biran N, Siegel D, Berdeja JG, Raje N, Cornell RF, Alsina M, Kovacsovics T, Fang B, Kimball AS, Landgren O.

Am J Hematol. 2019 Jul;94(7):794-802. doi: 10.1002/ajh.25498. Epub 2019 May 13.

33.

Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab.

Kimball AB, Kerbusch T, van Aarle F, Kulkarni P, Li Q, Blauvelt A, Papp KA, Reich K, Montgomery D.

Br J Dermatol. 2019 Mar 27. doi: 10.1111/bjd.17918. [Epub ahead of print]

PMID:
30916381
34.

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.

Jemec GBE, Okun MM, Forman SB, Gulliver WPF, Prens EP, Mrowietz U, Armstrong AW, Geng Z, Gu Y, Williams DA, Teixeira HD, Kimball AB.

Br J Dermatol. 2019 Nov;181(5):967-975. doi: 10.1111/bjd.17919. Epub 2019 Aug 14.

PMID:
30916379
35.

Reply to: "Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment".

Savage KT, Flood KS, Popatia S, Golbari NM, Salian P, Kimball AB, Porter ML.

J Am Acad Dermatol. 2019 Jul;81(1):e19-e20. doi: 10.1016/j.jaad.2019.03.051. Epub 2019 Mar 23. No abstract available.

PMID:
30914340
36.

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y.

J Am Acad Dermatol. 2019 Jul;81(1):76-90. doi: 10.1016/j.jaad.2019.02.067. Epub 2019 Mar 11. Review.

PMID:
30872156
37.

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y.

J Am Acad Dermatol. 2019 Jul;81(1):91-101. doi: 10.1016/j.jaad.2019.02.068. Epub 2019 Mar 11. Review.

PMID:
30872149
38.

Strengthening Public Health Leadership in Africa: An Innovative Fellowship Program.

Kimball AM, Harper D, Creamer K, Adeyemi A, Yates R, Lillywhite L, Told M, Heymann DL.

Acad Med. 2019 Aug;94(8):1146-1149. doi: 10.1097/ACM.0000000000002707.

39.

Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320).

Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Håkansson S, Lindqvist J, Farooqi A, Katheria A, Sauberan J, Singh J, Nelson K, Wickremasinghe A, Dong L, Hassinger DC, Aucott SW, Hayashi M, Heuchan AM, Carey WA, Derrick M, Wolf IS, Kimball A, Sankar M, Leone T, Perez J, Serize A, Clyman RI.

J Perinatol. 2019 May;39(5):599-607. doi: 10.1038/s41372-019-0347-4. Epub 2019 Mar 8.

40.

Use of biologics in pregnancy: limitations stemming from clinical trials and registry experience.

Flood KS, Porter ML, Kimball AB.

J Eur Acad Dermatol Venereol. 2019 Aug;33(8):e276-e277. doi: 10.1111/jdv.15552. Epub 2019 Mar 29. No abstract available.

PMID:
30848856
41.

Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28.

Papp KA, Reich K, Blauvelt A, Kimball AB, Gooderham M, Tyring SK, Sinclair R, Thaci D, Li Q, Cichanowitz N, Green S, La Rosa C.

J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1098-1106. doi: 10.1111/jdv.15400. Epub 2019 Mar 5.

PMID:
30838709
42.

Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy.

Tu MM, Lee FYF, Jones RT, Kimball AK, Saravia E, Graziano RF, Coleman B, Menard K, Yan J, Michaud E, Chang H, Abdel-Hafiz HA, Rozhok AI, Duex JE, Agarwal N, Chauca-Diaz A, Johnson LK, Ng TL, Cambier JC, Clambey ET, Costello JC, Korman AJ, Theodorescu D.

Sci Adv. 2019 Feb 20;5(2):eaav2437. doi: 10.1126/sciadv.aav2437. eCollection 2019 Feb.

43.

Histone Methylation Directs Myeloid TLR4 Expression and Regulates Wound Healing following Cutaneous Tissue Injury.

Davis FM, Kimball A, denDekker A, Joshi AD, Boniakowski AE, Nysz D, Allen RM, Obi A, Singer K, Henke PK, Moore BB, Kunkel SL, Gallagher KA.

J Immunol. 2019 Mar 15;202(6):1777-1785. doi: 10.4049/jimmunol.1801258. Epub 2019 Feb 1.

PMID:
30710046
44.

An assessment of the relative impact of hidradenitis suppurativa, psoriasis, and obesity on quality of life.

Storer MA, Danesh MJ, Sandhu ME, Pascoe V, Kimball AB.

Int J Womens Dermatol. 2018 Oct 11;4(4):198-202. doi: 10.1016/j.ijwd.2018.08.009. eCollection 2018 Dec.

45.

Clinical Goals and Barriers to Effective Psoriasis Care.

Strober BE, van der Walt JM, Armstrong AW, Bourcier M, Carvalho AVE, Chouela E, Cohen AD, de la Cruz C, Ellis CN, Finlay AY, Gottlieb AB, Gudjonsson JE, Iversen L, Kleyn CE, Leonardi CL, Lynde CW, Ryan C, Theng CT, Valenzuela F, Vender R, Wu JJ, Young HS, Kimball AB.

Dermatol Ther (Heidelb). 2019 Mar;9(1):5-18. doi: 10.1007/s13555-018-0279-5. Epub 2018 Dec 21.

46.

Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies.

Reich K, Papp KA, Armstrong AW, Wasfi Y, Li S, Shen YK, Randazzo B, Song M, Kimball AB.

Br J Dermatol. 2019 May;180(5):1039-1049. doi: 10.1111/bjd.17454.

PMID:
30485400
47.

Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR.

Dimopoulos M, Siegel D, White DJ, Boccia R, Iskander KS, Yang Z, Kimball AS, Mezzi K, Ludwig H, Niesvizky R.

Blood. 2019 Jan 10;133(2):147-155. doi: 10.1182/blood-2018-06-860015. Epub 2018 Nov 26.

48.

The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis.

Kimball AB, Sundaram M, Gauthier G, Guérin A, Pivneva I, Singh R, Ganguli A.

Dermatol Ther (Heidelb). 2018 Dec;8(4):557-569. doi: 10.1007/s13555-018-0264-z. Epub 2018 Oct 10.

49.

Whole body heat exposure modulates acute glucose metabolism.

Kimball AL, McCue PM, Petrie MA, Shields RK.

Int J Hyperthermia. 2018;35(1):644-651. doi: 10.1080/02656736.2018.1516303. Epub 2018 Oct 10.

PMID:
30303421
50.

Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa.

Porter ML, Golbari NM, Lockwood SJ, Kimball AB.

Semin Cutan Med Surg. 2018 Sep;37(3):182-189. doi: 10.12788/j.sder.2018.041. Review.

PMID:
30215636

Supplemental Content

Loading ...
Support Center